Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$981M |
| 2 |
Chevron
CVX
|
+$718M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$469M |
| 4 |
Shopify
SHOP
|
+$439M |
| 5 |
Meta Platforms (Facebook)
META
|
+$401M |
Top Sells
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 3 |
Tesla
TSLA
|
+$543M |
| 4 |
Verizon
VZ
|
+$535M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| 1 | Healthcare | 19.41% |
| 2 | Technology | 16.81% |
| 3 | Consumer Staples | 11.14% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Financials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4101
Kaixin Holdings
KXIN
$9.2M
| $24K | ﹤0.01% |
+26
| New | +$24K |
|
4102
PainReform
PRFX
$2.7M
| $24K | ﹤0.01% |
105
+16
| +18% | +$3.66K |
|
4103
Performance Shipping
PSHG
$23.9M
| $24K | ﹤0.01% |
2,956
-453
| -13% | -$3.68K |
|
4104
BioVie
BIVI
$13.5M
| $23K | ﹤0.01% |
+160
| New | +$23K |
|
4105
InMed Pharmaceuticals
INM
$4.5M
| $23K | ﹤0.01% |
99
+9
| +10% | +$2.09K |
|
4106
Motorsport Games
MSGM
$15M
| $23K | ﹤0.01% |
+3,451
| New | +$23K |
|
|
COMS
4107
DELISTED
COMSovereign Holding Corp. Common Stock
COMS
| $23K | ﹤0.01% |
1,334
+731
| +121% | +$12.6K |
|
|
EVAX
4108
Evaxion A/S American Depositary Share
EVAX
$17.7M
| $22K | ﹤0.01% |
+232
| New | +$22K |
|
4109
Sonnet BioTherapeutics
SONN
$21.3M
| $22K | ﹤0.01% |
32
-699
| -96% | -$481K |
|
4110
BioCardia
BCDA
$12.2M
| $21K | ﹤0.01% |
987
+74
| +8% | +$1.57K |
|
4111
Galmed Pharmaceuticals
GLMD
$8M
| $21K | ﹤0.01% |
+176
| New | +$21K |
|
4112
Precipio
PRPO
$34.4M
| $21K | ﹤0.01% |
+1,010
| New | +$21K |
|
|
SCNI
4113
Scinai Immunotherapeutics
SCNI
$1.51M
| $21K | ﹤0.01% |
+183
| New | +$21K |
|
4114
Taoping
TAOP
$5.06M
| $21K | ﹤0.01% |
65
-53
| -45% | -$17.1K |
|
4115
Xcel Brands
XELB
$7M
| $21K | ﹤0.01% |
1,745
-1,310
| -43% | -$15.8K |
|
4116
Zhongchao
ZCMD
$28M
| $21K | ﹤0.01% |
1,650
+90
| +6% | +$1.15K |
|
|
BACK
4117
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
| $21K | ﹤0.01% |
858
-855
| -50% | -$20.9K |
|
4118
Kiora Pharmaceuticals
KPRX
$9.03M
| $20K | ﹤0.01% |
116
-144
| -55% | -$24.8K |
|
4119
NRX Pharmaceuticals
NRXP
$74.9M
| $20K | ﹤0.01% |
3,290
-10,610
| -76% | -$64.5K |
|
4120
Reviva Pharmaceuticals
RVPH
$30.4M
| $20K | ﹤0.01% |
18,200
+5,500
| +43% | +$6.04K |
|
4121
Tenax Therapeutics
TENX
$27.4M
| $20K | ﹤0.01% |
41
-1
| -2% | -$488 |
|
|
TMDI
4122
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
| $20K | ﹤0.01% |
38,500
-87,147
| -69% | -$45.3K |
|
|
VIVE
4123
DELISTED
VIVEVE MED INC
VIVE
| $20K | ﹤0.01% |
29,800
-29,649
| -50% | -$19.9K |
|
4124
Baosheng Media Group
BAOS
$4.77M
| $19K | ﹤0.01% |
2,810
+643
| +30% | +$4.35K |
|
|
EZGO
4125
EZGO Technologies
EZGO
$784K
| $19K | ﹤0.01% |
650
-425
| -40% | -$12.4K |
|